Citation Impact
Citing Papers
Antioxidant effects of resveratrol in the cardiovascular system
2016
Alpelisib for PIK3CA -Mutated, Hormone Receptor–Positive Advanced Breast Cancer
2019 Standout
Evolution of the Cancer Stem Cell Model
2014 Standout
Best Practices in Adolescent and Young Adult Patients with Acute Lymphoblastic Leukemia: A Focus on Asparaginase
2015
CD19-targeted chimeric antigen receptor T-cell therapy for acute lymphoblastic leukemia
2015
Recent advances in immunotherapies: from infection and autoimmunity, to cancer, and back again
2018 StandoutNobel
The functional sites of miRNAs and lncRNAs in gastric carcinogenesis
2015
Gender differences in depression in representative national samples: Meta-analyses of diagnoses and symptoms.
2017 Standout
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
2020 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects
2020 Standout
Dapagliflozin, metformin XR, or both: initial pharmacotherapy for type 2 diabetes, a randomised controlled trial
2012
Acute lymphoblastic leukaemia
2013
A Health-Care System Perspective on Implementing Genomic Medicine: Pediatric Acute Lymphoblastic Leukemia as a Paradigm
2013
Relapsed childhood acute lymphoblastic leukaemia
2013
Delivery technologies for cancer immunotherapy
2019 Standout
Dealing With Missing Outcome Data in Randomized Trials and Observational Studies
2011
Functional connectome fingerprinting: identifying individuals using patterns of brain connectivity
2015 Standout
Use of Genome Engineering to Create Patient Specific MLL Translocations in Primary Human Hematopoietic Stem and Progenitor Cells
2015
Toward the future of psychiatric diagnosis: the seven pillars of RDoC
2013 Standout
Relapse-specific mutations in NT5C2 in childhood acute lymphoblastic leukemia
2013
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
2018 Standout
Tumour heterogeneity and cancer cell plasticity
2013 StandoutNature
Points to Consider: Ethical, Legal, and Psychosocial Implications of Genetic Testing in Children and Adolescents
2015 Standout
CAR-T cell therapy: current limitations and potential strategies
2021 Standout
CRISPR-Cas9-induced t(11;19)/MLL-ENL translocations initiate leukemia in human hematopoietic progenitor cells in vivo
2017 StandoutNobel
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
2014 Standout
Novel immunotherapies for adult patients with B-lineage acute lymphoblastic leukemia
2017
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
2014 Standout
Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial
2010
An Audit Strategy for Progression-Free Survival
2011
Chimeric antigen receptor T-cell therapy — assessment and management of toxicities
2017 Standout
The Effects of Stroke Type, Locus, and Extent on Long-Term Outcome of Gait Rehabilitation
2015
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
The Fibroblast Growth Factor signaling pathway
2015 Standout
Long Noncoding RNA and Cancer: A New Paradigm
2017 Standout
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
Where do we stand in the treatment of relapsed acute lymphoblastic leukemia?
2012
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2018 Standout
Agnostic notes on regression adjustments to experimental data: Reexamining Freedman’s critique
2013
Resveratrol, human health and winemaking perspectives
2017
Sampling‐Based versus Design‐Based Uncertainty in Regression Analysis
2020 StandoutNobel
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
2018 Standout
A causal bootstrap
2021 StandoutNobel
Chimeric Antigen Receptor Therapy
2018 Standout
Cancer treatment and survivorship statistics, 2016
2016 Standout
Causal Inference for Statistics, Social, and Biomedical Sciences: An Introduction
2015 StandoutNobel
Cancer treatment and survivorship statistics, 2019
2019 Standout
Mechanisms of Diabetic Complications
2013 Standout
Long‐term glycaemic response and tolerability of dapagliflozin versus a sulphonylurea as add‐on therapy to metformin in patients with type 2 diabetes: 4‐year data
2015
Intrachromosomal Amplification of Chromosome 21 Is Associated With Inferior Outcomes in Children With Acute Lymphoblastic Leukemia Treated in Contemporary Standard-Risk Children's Oncology Group Studies: A Report From the Children's Oncology Group
2013
Polyphenols and Human Health: The Role of Bioavailability
2021 Standout
Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic Leukemia
2016
Adjusting Treatment Effect Estimates by Post-Stratification in Randomized Experiments
2012
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia
2016 Standout
Metformin extended‐release versus immediate‐release: A n international, randomized, double‐blind, head‐to‐head trial in pharmacotherapy‐naïve patients with type 2 diabetes
2017
Where do we stand in the treatment of relapsed acute lymphoblastic leukemia?
2012
Cancer treatment and survivorship statistics, 2014
2014 Standout
Works of Xiaomin Lu being referenced
miR-26a Suppresses Tumor Growth and Metastasis by Targeting FGF9 in Gastric Cancer
2013
Covariate adjustment for two‐sample treatment comparisons in randomized clinical trials: A principled yet flexible approach
2007
Safety and metabolic outcomes of resveratrol supplementation in older adults: results of a twelve-week, placebo-controlled pilot study
2014
Re‐induction chemoimmunotherapy with epratuzumab in relapsed acute lymphoblastic leukemia (ALL): Phase II results from Children's Oncology Group (COG) study ADVL04P2
2015
Improved Survival for Children and Adolescents With Acute Lymphoblastic Leukemia Between 1990 and 2005: A Report From the Children's Oncology Group
2012
Prediction of responders for outcome measures of Locomotor Experience Applied Post Stroke trial
2014
Reinduction Chemoimmunotherapy with Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL) in Children, Adolescents and Young Adults: Results From Children's Oncology Group (COG) Study ADVL04P2
2011
Improving the efficiency of the log-rank test using auxiliary covariates
2008